Search
for
Sort by
Research 30 of 1000+
- 644 Tumor cell adhesion as a risk factor for SLN metastasis and predictor of disease recurrence in primary cutaneous melanoma
- The Comparison of In Vitro Photosensitizing Efficacy of Curcumin-Loaded Liposomes Following Photodynamic Therapy on Melanoma MUG-Mel2, Squamous Cell Carcinoma SCC-25, and Normal Keratinocyte HaCaT Cells
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- 646 SOX4 is essential for melanoma tumorigenesis
- Scalp melanoma after antihair loss mesotherapy
- Hair and nail adverse events during treatment with target therapies for metastatic melanoma
- Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
- ‘Malignant melanoma microecosystem’: Immunohistopathological insights into the stromal cell phenotype
- The Influence of Flightless I: Regeneration versus Wound Healing
- Models for Skin Cancer
- Cutaneous adverse effects of targeted therapies
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Successful in situ 5-aminolevulinic acid photodynamic therapy in a 53-year-old female with cutaneous squamous cell carcinoma
- Coexistence of a Basal Cell Carcinoma and Leiomyosarcoma: An Unusual Collision Tumor
- Malignant Melanoma and Its Stromal Nonimmune Microecosystem
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Prostaglandins and Skin Cancer: An Old Pathway With New Insights in Cutaneous Oncology
- News in brief
- 642 Uncovering the role of UV exposure history and genetics in determining skin sun damage
- Highlights
- Coexistence of a Basal Cell Carcinoma and Leiomyosarcoma
- Editors' Picks
- 647 NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing caspase-3 activity in human melanoma
- RAGE and Its Ligands in Melanoma
- Biological therapy in the treatment of melanoma
- Aldesleukin
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
- Updates from the British Association of Dermatologists 91st Annual Meeting, 5-7 July 2011, London, U.K.